Marie Wildt

1.2k total citations
35 papers, 868 citations indexed

About

Marie Wildt is a scholar working on Pathology and Forensic Medicine, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marie Wildt has authored 35 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 17 papers in Dermatology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marie Wildt's work include Systemic Sclerosis and Related Diseases (29 papers), Dermatologic Treatments and Research (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Marie Wildt is often cited by papers focused on Systemic Sclerosis and Related Diseases (29 papers), Dermatologic Treatments and Research (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). Marie Wildt collaborates with scholars based in Sweden, United Kingdom and Italy. Marie Wildt's co-authors include A Scheja, Roger Hesselstrand, A Akesson, Gunilla Westergren‐Thorsson, Dirk M. Wuttge, Leif Bjermer, Frank A. Wollheim, Kristofer Andréasson, Anita Åkesson and Pierre Geborek and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

Marie Wildt

34 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Wildt Sweden 20 524 276 270 141 136 35 868
Anita Åkesson Sweden 13 654 1.2× 250 0.9× 288 1.1× 150 1.1× 179 1.3× 14 1.0k
Soumya Chatterjee United States 18 712 1.4× 254 0.9× 312 1.2× 180 1.3× 124 0.9× 68 1.1k
Akio Yamakage Japan 14 487 0.9× 249 0.9× 167 0.6× 69 0.5× 195 1.4× 45 847
Faye N. Hant United States 15 537 1.0× 151 0.5× 379 1.4× 56 0.4× 238 1.8× 32 842
Wanda Maglione Italy 18 579 1.1× 245 0.9× 148 0.5× 202 1.4× 298 2.2× 38 1.1k
Giuseppina Abignano United Kingdom 17 477 0.9× 221 0.8× 114 0.4× 83 0.6× 127 0.9× 59 727
Irene Miniati Italy 20 1.1k 2.2× 515 1.9× 237 0.9× 227 1.6× 223 1.6× 30 1.4k
Paulius Venalis Sweden 12 375 0.7× 177 0.6× 268 1.0× 132 0.9× 531 3.9× 16 1.3k
C.P. Denton United Kingdom 11 461 0.9× 155 0.6× 173 0.6× 71 0.5× 101 0.7× 28 620
Tatiana Nevskaya Canada 14 293 0.6× 123 0.4× 146 0.5× 44 0.3× 132 1.0× 33 641

Countries citing papers authored by Marie Wildt

Since Specialization
Citations

This map shows the geographic impact of Marie Wildt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Wildt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Wildt more than expected).

Fields of papers citing papers by Marie Wildt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Wildt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Wildt. The network helps show where Marie Wildt may publish in the future.

Co-authorship network of co-authors of Marie Wildt

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Wildt. A scholar is included among the top collaborators of Marie Wildt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Wildt. Marie Wildt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wildt, Marie, et al.. (2023). Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis. Lara D. Veeken. 63(2). 385–391. 3 indexed citations
2.
Sohrabian, Azita, Elizabeth R. Volkmann, Marie Wildt, et al.. (2023). Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study. Arthritis Research & Therapy. 25(1). 162–162. 12 indexed citations
3.
Santiago, Tânia, Eduardo Santos, Barbara Ruaro, et al.. (2022). Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group. RMD Open. 8(2). e002371–e002371. 10 indexed citations
4.
Wildt, Marie, et al.. (2022). Dipeptidyl peptidase 4 expression is not associated with an activated fibroblast phenotype in idiopathic pulmonary fibrosis. Frontiers in Pharmacology. 13. 953771–953771. 3 indexed citations
5.
6.
Dinsdale, Graham, Tonia Moore, Neil O’Leary, et al.. (2017). Quantitative outcome measures for systemic sclerosis-related Microangiopathy – Reliability of image acquisition in Nailfold Capillaroscopy. Microvascular Research. 113. 56–59. 19 indexed citations
7.
Westergren‐Thorsson, Gunilla, Emil Tykesson, Emma Åhrman, et al.. (2016). Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis. The International Journal of Biochemistry & Cell Biology. 83. 27–38. 50 indexed citations
8.
Wuttge, Dirk M., Anting Liu Carlsen, Marie Wildt, et al.. (2015). Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis. Lara D. Veeken. 54(11). 2100–2107. 29 indexed citations
9.
Hesselstrand, Roger, Marie Wildt, Gracijela Božović, et al.. (2013). Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Respiratory Medicine. 107(7). 1079–1086. 53 indexed citations
10.
Hällgren, Oskar, Johan Malmström, Lars Malmström, et al.. (2012). Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β. PubMed. 5(1). 6–6. 17 indexed citations
11.
Hofstee, Herman M.A., Erik H. Serné, Chris Roberts, et al.. (2012). Comment on: A multicentre study on the reliability of qualitative and quantitative nailfold videocapillaroscopy assessment: reply. Lara D. Veeken. 51(10). 1922–1922. 15 indexed citations
12.
Hofstee, Herman M.A., Erik H. Serné, Chris Roberts, et al.. (2011). A multicentre study on the reliability of qualitative and quantitative nail-fold videocapillaroscopy assessment. Lara D. Veeken. 51(4). 749–755. 53 indexed citations
13.
Scheja, A, et al.. (2011). Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations. Scandinavian Journal of Rheumatology. 40(6). 457–461. 4 indexed citations
14.
Hesselstrand, Roger, et al.. (2010). Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scandinavian Journal of Rheumatology. 40(2). 127–132. 36 indexed citations
15.
Hesselstrand, Roger, A Scheja, Marie Wildt, & A Akesson. (2007). High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Lara D. Veeken. 47(1). 84–87. 95 indexed citations
16.
Wildt, Marie, Roger Hesselstrand, Agneta Åkesson, & A Scheja. (2007). Simple counting of nailfold capillary density in suspected systemic sclerosis – 9 years' experience. Scandinavian Journal of Rheumatology. 36(6). 452–457. 10 indexed citations
17.
Larsen, Kristoffer, Johan Malmström, Marie Wildt, et al.. (2006). Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma. Respiratory Research. 7(1). 11–11. 38 indexed citations
18.
Scheja, A, Kristoffer Larsen, Lizbet Todorova, et al.. (2006). BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis. European Respiratory Journal. 29(3). 446–452. 19 indexed citations
19.
Larsen, Kristoffer, Ellen Tufvesson, Johan Malmström, et al.. (2004). Presence of Activated Mobile Fibroblasts in Bronchoalveolar Lavage from Patients with Mild Asthma. American Journal of Respiratory and Critical Care Medicine. 170(10). 1049–1056. 49 indexed citations
20.
Scheja, A, Anita Åkesson, Pierre Geborek, et al.. (2001). Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Research & Therapy. 3(3). 178–82. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anita Åkesson Breakdown of academic impact, for papers by Soumya Chatterjee Breakdown of academic impact, for papers by Akio Yamakage Breakdown of academic impact, for papers by Faye N. Hant Breakdown of academic impact, for papers by Wanda Maglione Breakdown of academic impact, for papers by Giuseppina Abignano Breakdown of academic impact, for papers by Irene Miniati Breakdown of academic impact, for papers by Paulius Venalis Breakdown of academic impact, for papers by C.P. Denton Breakdown of academic impact, for papers by Tatiana Nevskaya
Rankless by CCL
2026